<DOC>
	<DOCNO>NCT01201070</DOCNO>
	<brief_summary>General specific objective search : evaluate effect administration Antithrombin III ( ATIII ) activation coagulation system fibrinolysis , platelet function , inflammatory response marker organ damage patient undergoing cardiac surgery cardiopulmonary bypass ( CPB ) low plasma level post-operative Antithrombin ( AT ) .</brief_summary>
	<brief_title>Study Administration Of Antithrombin Patients With Low Plasmatic Levels Antithrombin After Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Aortic Valve Insufficiency</mesh_term>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<mesh_term>Mitral Valve Stenosis</mesh_term>
	<mesh_term>Antithrombins</mesh_term>
	<mesh_term>Antithrombin III</mesh_term>
	<criteria>All patient candidate cardiac surgery intervention extracorporeal circulation positive history allergic reaction AT III cardiac surgery `` OffPump '' administration AT surgery within 48 h treatment drug nonsteroidal steroid within 48 h prior disorder coagulation platelet &lt; 30,000 preexist IRC dialysis treatment severe liver failure enlistment another trial last 30 day hypothermia emergency reopen length CEC &gt; 180 minute subject incapable give legal consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>